Holen Sie sich die Stockscreener-App
1.555
1.58%
-0.025
Schlusskurs vom Vortag:
$1.58
Offen:
$1.57
24-Stunden-Volumen:
454.23K
Relative Volume:
0.83
Marktkapitalisierung:
$82.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-77.74M
KGV:
-1.0512
EPS:
-1.4793
Netto-Cashflow:
$-73.61M
1W Leistung:
-5.18%
1M Leistung:
+40.09%
6M Leistung:
+26.42%
1J Leistung:
+25.40%
1-Tages-Spanne:
$1.54
$1.60
1-Wochen-Bereich:
$1.54
$1.73
52-Wochen-Spanne:
$0.81
$1.88
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Firmenname
Pmv Pharmaceuticals Inc
Sektor
Branche
Telefon
(609) 642-6670
Adresse
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.55 | 84.07M | 0 | -77.74M | -73.61M | -1.4793 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.62 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.19 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.58 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.30 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
283.63 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-05-13 | Eingeleitet | Craig Hallum | Buy |
| 2024-04-12 | Eingeleitet | Jefferies | Buy |
| 2023-12-27 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-03-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-22 | Hochstufung | Goldman | Neutral → Buy |
| 2021-08-19 | Eingeleitet | Oppenheimer | Perform |
| 2021-08-02 | Eingeleitet | Guggenheim | Buy |
| 2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-20 | Eingeleitet | BofA Securities | Buy |
| 2020-10-20 | Eingeleitet | Cowen | Outperform |
| 2020-10-20 | Eingeleitet | Evercore ISI | Outperform |
| 2020-10-20 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Pmv Pharmaceuticals Inc Aktie (PMVP) Neueste Nachrichten
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology - TipRanks
PMV Pharmaceuticals (NASDAQ:PMVP) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Trend Recap: Does TriNet Group Inc have pricing powerEarnings Overview Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn
Risk On: Whats the outlook for PMV Pharmaceuticals Incs sectorWeekly Trend Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
PMVP Reports Positive Phase 2 Results, Eyes 2027 NDA Submission - GuruFocus
PMV Pharma (PMVP) Reports Decline in Cash Reserves by Year-End 2 - GuruFocus
PMV Pharmaceuticals Reports Progress in PYNNACLE Trial of Rezatapopt for Ovarian Cancer and Announces Orphan Drug Designation from FDA - Quiver Quantitative
PMV Pharmaceuticals 10-K: Revenue $0, EPS $(1.48) — FY2025 results - TradingView
PMVP: Net loss widened to $77.7M as rezatapopt advanced in trials; cash runway extends to Q2 2027 - TradingView
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights - Yahoo Finance
PMVP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Short Interest Update - MarketBeat
PMV Pharmaceuticals Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Health Rounds: Researchers find cellular clues to explain faster pain recovery in men - marketscreener.com
PMV Pharma’s rezatapopt study published in New England Journal - Investing.com Australia
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
PMV Pharmaceuticals (PMVP) Publishes Positive Phase 1 Results fo - GuruFocus
PMV Pharma’s rezatapopt study published in New England Journal By Investing.com - Investing.com UK
New England Journal of Medicine Publishes First-in-Human - GlobeNewswire
Risk Analysis: Is PMV Pharmaceuticals Inc benefiting from interest rate changes2025 Biggest Moves & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
PMV Pharmaceuticals (PMVP) to Release Quarterly Earnings on Monday - Defense World
Avadel Pharmaceuticals (AVDL) to Release Earnings on Monday - Defense World
Decliners Report: Can NSYS lead its sector in growthTrade Exit Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Signal Recap: How much upside does LNKB haveJuly 2025 PostEarnings & Verified Swing Trading Watchlists - baoquankhu1.vn
Dow Update: Is Oxbridge Re Holdings Limited benefiting from interest rate changes2025 Geopolitical Influence & Short-Term High Return Ideas - baoquankhu1.vn
Growth Review: Is Accretion Acquisition Corp Equity Right stock risky to hold nowMarket Activity Summary & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Will PMV Pharmaceuticals Inc outperform its industry peersJuly 2025 WrapUp & Weekly Market Pulse Alerts - baoquankhu1.vn
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 0.9%Time to Buy? - MarketBeat
Fund Flows: Whats the RSI of PMV Pharmaceuticals Inc stockMarket Sentiment Report & Fast Gaining Stock Reports - baoquankhu1.vn
Why Columbus Acquisition Corp stock is a value investor pickRate Cut & Weekly Watchlist of Top Performers - mfd.ru
Will NDLS stock deliver better than expected guidanceWeekly Trend Report & Weekly Stock Breakout Alerts - mfd.ru
PMVP PE Ratio & Valuation, Is PMVP Overvalued - Intellectia AI
Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL) and OrganiGram Holdings (OGI) - The Globe and Mail
Guidance Update: Is PMV Pharmaceuticals Incs ROE strong enoughJuly 2025 PreEarnings & Weekly Stock Breakout Alerts - baoquankhu1.vn
Fed Watch: Will PMV Pharmaceuticals Inc outperform its industry peersAnalyst Upgrade & AI Powered Market Entry Strategies - baoquankhu1.vn
PMV Pharmaceuticals: Key Catalysts Approach in Q1 2026 - AD HOC NEWS
Tech Rally: Whats the RSI of PMV Pharmaceuticals Inc stockMarket Volume Summary & Technical Entry and Exit Tips - baoquankhu1.vn
Support Test: Whats the outlook for PMV Pharmaceuticals Incs sectorProduct Launch & Detailed Earnings Play Alerts - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: Palvella Therapeutics (PVLA), Xeris Pharmaceuticals (XERS) - The Globe and Mail
Caesarstone And 2 More Penny Stocks Worth Watching - simplywall.st
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 3.4%Here's Why - MarketBeat
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Up 3.4% – Here’s Why - Defense World
Will PMV Pharmaceuticals (NASDAQ:PMVP) Spend Its Cash Wisely? - simplywall.st
Weekly Earnings: Can MTRX generate free cash flowQuarterly Trade Summary & Safe Entry Zone Identification - baoquankhu1.vn
Stock Market Recap: Does LEGTWS have strong EBITDA marginsBear Alert & Low Risk Investment Opportunities - baoquankhu1.vn
Options Flow: Will Ford Motor Company outperform tech stocksGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn
MBX Biosciences appoints Laurie Stelzer to board of directors By Investing.com - Investing.com Nigeria
MBX Biosciences appoints Laurie Stelzer to board of directors - Investing.com
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair - The Manila Times
Laurie Stelzer, ex-CFO at Mirati and Arena, joins MBX board - Stock Titan
Aug EndMonth: Will IMXI benefit from green energy policies2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pmv Pharmaceuticals Inc-Aktie (PMVP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
0.18%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):